STRS Ohio’s Tourmaline Bio TRML Stock Holding History

STRS Ohio’s Portfolio TRML Stock Details TRML Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-210	Closed	-$3K	–	2100
2023 Q1	$3K	Hold	210	–	–	﹤0.01%	1927
2022 Q4	$2K	Hold	210	–	–	﹤0.01%	1969
2022 Q3	$5K	Hold	210	–	–	﹤0.01%	1987
2022 Q2	$9K	Hold	210	–	–	﹤0.01%	2002
2022 Q1	$20K	Hold	210	–	–	﹤0.01%	2048
2021 Q4	$32K	Hold	210	–	–	﹤0.01%	2063
2021 Q3	$28K	Hold	210	–	–	﹤0.01%	2155
2021 Q2	$30K	Buy	+210	New	+$32.2K	﹤0.01%	2153

Other funds holding TRML

Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return

QUSVM

Qiming U.S. Ventures Management Bellevue, Washington $55.6M AUM 98.09% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

BCM

BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

GPP

Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return

STRS Ohio's TRML Position: Q2 2023 in Review

STRS Ohio sold out of Tourmaline Bio (TRML) in Q2 2023, closing a stake of 210 shares — an estimated $3K sold.

STRS Ohio first reported a position in TRML in Q2 2021 and held it in 8 quarters. The position peaked at $32K in Q4 2021. 58 funds tracked by Wall St. Rank hold TRML as of Q2 2023.

STRS Ohio reported no remaining Tourmaline Bio position as of Q2 2023 after selling out during the quarter.
STRS Ohio sold 210 Tourmaline Bio shares in Q2 2023, an estimated $3K.
STRS Ohio first reported a position in Tourmaline Bio in Q2 2021 and held it in 8 quarters.
STRS Ohio's Tourmaline Bio position peaked at $32K in Q4 2021.
58 funds tracked by Wall St. Rank held Tourmaline Bio as of Q2 2023.

Based on STRS Ohio's 13F filing for Q2 2023, filed 31 Jul 2023.